BURDEN OF LYMPHOMA IN CHINA, 1990−2019: AN ANALYSIS OF GLOBAL BURDEN OF DISEASES, INJURIES, AND RISK FACTORS STUDY 2019

Background: China is facing the aggravating disease burden of lymphoma. However, accurate information about lymphoma at national and provincial levels limited. Methods: Following general analytical strategy used in Global Burden Diseases, Injuries, Risk Factors Study 2019, age-, sex- province-specific incidence, mortality prevalence Hodgkin (HL) non-Hodgkin (NHL) were analyzed. Lymphoma was assessed by methods mortality, disability-adjusted life years (DALYs). Results: The estimated number age-standardized rates DALYs per 100,000 population 86,171.85 4.95 for HL, 1,306,247.77 71.00 NHL, respectively. There 9,470 new cases 2,710 deaths 91,950 44,310 NHL. Older individuals had higher with a peak age-specific reached age group 70-74 both HL males 2 folds than that females. Moreover, disparities observed across provinces. Between 1990 kept downward trend decrease 57.8% DALY 74.4% rates, while NHL aggravated an increase 100.9% 15.6% rates. Conclusion: showed heterogeneous change pattern varied sex, age, provinces, steady improvement fluctuant Keywords: lymphoma, Non-Hodgkin (Pediatric, Adolescent, Young Adult) No conflicts interests pertinent to abstract.